Want to see SE:ONCOZ full AI Analyst Report?
OncoZenge AB (ONCOZ) Ratios
OncoZenge AB Ratios
SE:ONCOZ's free cash flow for Q2 2026 was $-2.19M. For the 2026 fiscal year, SE:ONCOZ's free cash flow was increased by $0.00 and operating cash flow was $-2.19M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.01 | 3.09 | 7.94 | 10.29 | 10.63 |
| Quick Ratio | 1.01 | 3.09 | 7.94 | 10.29 | 10.63 |
| Cash Ratio | 0.44 | 2.60 | 7.43 | 9.98 | 10.44 |
| Solvency Ratio | -1.00 | -5.85 | 4.28 | -8.04 | -0.79 |
| Operating Cash Flow Ratio | -1.55 | -5.91 | -10.05 | -7.56 | -0.97 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -7.44M | $ 3.10M | $ 11.79M | $ 27.12M | $ 47.23M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.49 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | -12.78 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 1.08 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 1.08 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -26.13 | 1.15 | 1.09 | 1.09 | 1.06 |
| Debt Service Coverage Ratio | -93.91 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | -93.91 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.63 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | -0.24 | 0.44 | -1.74 | -10.53 | 10.47 |
| Profitability Margins | |||||
| Gross Profit Margin | -181.68% | 100.00% | 100.00% | 0.00% | 0.00% |
| EBIT Margin | -595.72% | -868500.00% | -530066.67% | 0.00% | 0.00% |
| EBITDA Margin | -595.72% | -868500.00% | 242200.00% | 0.00% | 0.00% |
| Operating Profit Margin | -595.72% | -868500.00% | -530066.67% | 0.00% | 0.00% |
| Pretax Profit Margin | -598.35% | -868800.00% | -530066.67% | 0.00% | 0.00% |
| Net Profit Margin | -598.35% | -868800.00% | -530066.67% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -598.35% | -868800.00% | -530066.67% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 107.06% | 79.40% |
| EBT Per EBIT | 100.44% | 100.03% | 100.00% | 100.00% | 100.00% |
| Return on Assets (ROA) | -103.93% | -75.98% | -78.18% | -126.44% | -4.56% |
| Return on Equity (ROE) | 2715.50% | -87.32% | -85.31% | -137.30% | -4.84% |
| Return on Capital Employed (ROCE) | -229.57% | -87.29% | -85.31% | -128.25% | -6.09% |
| Return on Invested Capital (ROIC) | -229.57% | -87.29% | -85.31% | -128.25% | -4.84% |
| Return on Tangible Assets | -187.82% | -189.53% | -117.88% | -155.26% | -7.04% |
| Earnings Yield | -19.44% | -19.78% | -43.94% | -72.41% | -2.87% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.56 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 1.10 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.17 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 1.68 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 323.35 | 263165.00 | 100861.67 | 0.00 | 0.00 |
| Days of Sales Outstanding | 653.96 | 263165.00 | 100861.67 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 330.61 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 653.96 | 263165.00 | 100861.67 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.08 | -0.75 | -1.46 | -1.88 | -0.41 |
| Free Cash Flow Per Share | -1.08 | -0.75 | -1.46 | -1.88 | -0.86 |
| Dividend Paid and CapEx Coverage Ratio | -1.00 | 0.00 | 0.00 | 0.00 | -0.89 |
| Capital Expenditure Coverage Ratio | -1.00 | 0.00 | 0.00 | 0.00 | -0.89 |
| Operating Cash Flow Coverage Ratio | -1.74 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | -4.90 | -8764.00 | -5694.33 | 0.00 | 0.00 |
| Free Cash Flow Yield | -15.92% | -19.95% | -47.20% | -34.27% | -7.48% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -5.16 | -5.07 | -2.28 | -1.38 | -34.84 |
| Price-to-Sales (P/S) Ratio | 30.78 | 43924.69 | 12064.64 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -139.70 | 4.41 | 1.94 | 1.90 | 1.69 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -6.28 | -5.01 | -2.12 | -2.92 | -13.38 |
| Price-to-Operating Cash Flow Ratio | -6.28 | -5.01 | -2.12 | -2.92 | -28.40 |
| Price-to-Earnings Growth (PEG) Ratio | -0.07 | 0.11 | 0.03 | -0.00 | -0.05 |
| Enterprise Value Multiple | -5.41 | -4.61 | 3.24 | 12.75 | -17.20 |
| Enterprise Value | 85.79M | 40.06M | 23.57M | 35.28M | 84.19M |
| EV to EBITDA | -5.41 | -4.61 | 3.24 | 12.75 | -17.20 |
| EV to Sales | 32.20 | 40061.69 | 7855.64 | 0.00 | 0.00 |
| EV to Free Cash Flow | -6.57 | -4.57 | -1.38 | -1.60 | -8.32 |
| EV to Operating Cash Flow | -6.57 | -4.57 | -1.38 | -1.60 | -17.66 |
| Tangible Book Value Per Share | -0.61 | 0.26 | 1.01 | 2.32 | 4.29 |
| Shareholders’ Equity Per Share | -0.05 | 0.85 | 1.59 | 2.90 | 6.86 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | -0.07 | 0.21 |
| Revenue Per Share | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -1.31 | -0.74 | -1.36 | -3.98 | -0.33 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.07 | 0.79 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 2.14 | 1.00 |
| Research & Development to Revenue | 4.14 | 1719.00 | 2464.67 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 8683.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.82 | 1.01 | 1.07 | 0.51 | 0.97 |
Currency in SEK